Advertisement

Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck

  • Carolyn Jameson
  • Gary Morgan
  • Carsten E. Palme
  • Michael Veness
Part of the Head and Neck Cancer Clinics book series (HNCC)

Abstract

Non-melanoma skin cancer (NMSC), comprising basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), is the most common malignancy worldwide. The incidence of NMSC is increasing with 2–3 million new diagnoses per year globally. Australia, with chronic high ultraviolet (UV) exposure, has the highest incidence of NMSC in the world, with the majority of cSCCs (70–90 %) arising on the sun-exposed skin of the head and neck (HN) in older Caucasian males [1–4].

Keywords

Sentinel Lymph Node Biopsy Adjuvant Radiotherapy National Comprehensive Cancer Network Merkel Cell Carcinoma Completion Lymph Node Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    de Vries E, van de Poll-Franse LV, Louwman WJ, et al. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005;152:481–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Locke J, Karimpour S, Young G, et al. Radiotherapy for epithelial skin cancers. Int J Radiat Oncol Biol Phys. 2001;51:748–55.CrossRefPubMedGoogle Scholar
  3. 3.
    Veness MJ, Porceddu S, Palme CE, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–31.CrossRefPubMedGoogle Scholar
  4. 4.
    Ebrahimi A, Moncrieff MD, Clark JR, et al. Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck. 2010;32:1288–94.CrossRefPubMedGoogle Scholar
  5. 5.
    Rodgers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283–7.Google Scholar
  6. 6.
    Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer. 1998;78:587–93.CrossRefPubMedGoogle Scholar
  7. 7.
    Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–1995: are primary prevention programs starting to have an effect? Int J Cancer. 1998;78:144–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20.CrossRefPubMedGoogle Scholar
  9. 9.
    Katz MH. Nonmelanoma skin cancer. Md Med J. 1997;46:239–42.PubMedGoogle Scholar
  10. 10.
    Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol. 2000;136:1524–30.CrossRefPubMedGoogle Scholar
  11. 11.
    Schmults CD, Karia PS, Carter JB, et al. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149:541–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Motley RJ, Kersey P, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2003;56:85–91.Google Scholar
  13. 13.
    Czarnecki D, Staples M, Mar A, et al. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology. 1994;189:52–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Wang JT, Palme CE, Morgan GJ, et al. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck. 2011;34:1524–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg. 2012;82:230–3.CrossRefPubMedGoogle Scholar
  16. 16.
    Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer. 2009;115:1883–91.CrossRefPubMedGoogle Scholar
  17. 17.
    Givi B, Andersen PE, Diggs BS, et al. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2011;33:999–1004.CrossRefPubMedGoogle Scholar
  18. 18.
    Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52:101–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Veness MJ, Morgan GJ, Palme CE, et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115:870–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. London: British Association of Dermatology (BAD); 2009. p. 34. http://www.guideline.gov/content.aspx?id=15882.
  21. 21.
    National Comprehensive Cancer Network (NCCN). Practice guidelines in oncology: basal cell and squamous cell skin cancers. Available at www.nccn.org/professionals/5hysician_gls/PDF/nmsc.pdf. Accessed on 24 Sept 2013.
  22. 22.
    Vauterin TJ, Veness MJ, Morgan GJ, et al. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2006;28:785–91.CrossRefPubMedGoogle Scholar
  23. 23.
    Hinerman RW, Indelicato DJ, Amdur RJ, et al. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope. 2008;118:1989–96.CrossRefPubMedGoogle Scholar
  24. 24.
    Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear and lip. J Am Acad Dermatol. 1992;26:976–90.CrossRefPubMedGoogle Scholar
  25. 25.
    Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. J Am Acad Dermatol. 1989;21:241–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Stein AL, Tahan SR. Histologic correlates of metastasis in primary invasive squamous cell carcinoma of the lip. J Cutan Pathol. 1994;21:16–21.CrossRefPubMedGoogle Scholar
  27. 27.
    Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1998;124:582–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Rodolico V, Barresi E, Di Lorenzo R, et al. Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27kip1 protein expression. Oral Oncol. 2004;40:92–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990;94:624–7.PubMedGoogle Scholar
  30. 30.
    Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification—part two. J Cutan Pathol. 2006;33:261–79.CrossRefPubMedGoogle Scholar
  31. 31.
    Breuninger H, Schaumburg-Lever G, Holzschuh J, et al. Desmoplastic squamous cell carcinoma of the skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer. 1997;79:915–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Ballantyne AJ. Perineural invasion by squamous cell carcinoma. J Dermatol Surg Oncol. 1984;10:502–4.CrossRefPubMedGoogle Scholar
  33. 33.
    Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Moh’s micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53:261–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Ross AS, Whalen FM, Elenitsas R, et al. Diameter of involved nerves predicts outcome in cutaneous squamous cell carcinoma with perineural invasion: an investigator blinded retrospective cohort study. Dermatol Surg. 2009;35:1859–66.CrossRefPubMedGoogle Scholar
  35. 35.
  36. 36.
    Brougham ND, Dennett ER, Cameron R, et al. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol. 2012;106:811–5.CrossRefPubMedGoogle Scholar
  37. 37.
    Huang CC, Boyce SM. Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Semin Cutan Med Surg. 2004;23:163–73.CrossRefGoogle Scholar
  38. 38.
    Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27:241–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg. 2003;112:57–63.CrossRefPubMedGoogle Scholar
  40. 40.
    Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Moh’s micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53:253–60.CrossRefPubMedGoogle Scholar
  41. 41.
    Duvvuri U, Simental Jr AA, D’Angelo G, et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope. 2004;114:2228–34.CrossRefPubMedGoogle Scholar
  42. 42.
    Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg. 2005;242:302–11; discussion 311–13.PubMedCentralPubMedGoogle Scholar
  43. 43.
    Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011;18:2529–37.PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Howle J, Veness M. Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead Hospital experience. Australas J Dermatol. 2012;53:26–31.CrossRefPubMedGoogle Scholar
  45. 45.
    Morton DL. Overview and update of the phase III MSLT-I and MSLT-II in melanoma. Clin Exp Metastasis. 2012;29:699–706.PubMedCentralCrossRefPubMedGoogle Scholar
  46. 46.
    Vermeeren L, Valdés Olmos RA, Klop WM, et al. SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck. 2011;33:1–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006;112 Suppl 109:1–15.CrossRefPubMedGoogle Scholar
  48. 48.
    Altinyollar H, Berberoglu U, Çelen O, et al. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol. 2002;28:72–4.CrossRefPubMedGoogle Scholar
  49. 49.
    Kwon S, Dong ZM, Wu PC. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol. 2011;9:80.PubMedCentralCrossRefPubMedGoogle Scholar
  50. 50.
  51. 51.
    Wong G, Chapman JR. Cancers after renal transplantation. Transplant Rev. 2008;22:141–9.CrossRefGoogle Scholar
  52. 52.
    Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation. 1990;49:506–9.CrossRefPubMedGoogle Scholar
  53. 53.
    Jensen P, Hansen S, Møller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177–86.CrossRefPubMedGoogle Scholar
  54. 54.
    Lindelöf B, Sigurgeirsson B, Gäbel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:513–9.PubMedGoogle Scholar
  55. 55.
    Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol. 2006;142:755–8.PubMedGoogle Scholar
  56. 56.
    Deeb R, Sharma S, Mahan M, et al. Head and neck cancer in transplant recipients. Laryngoscope. 2012;122:1566–9.CrossRefPubMedGoogle Scholar
  57. 57.
    Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996;61:715–21.CrossRefPubMedGoogle Scholar
  58. 58.
    Webb MC, Compton F, Andrews PA, et al. Skin tumours post-transplantation: a retrospective analysis of 28 years’ experience at a single centre. Transplant Proc. 1997;29:828–30.CrossRefPubMedGoogle Scholar
  59. 59.
    Veness MJ. The important role of radiotherapy in patients with NMSC and other cutaneous entities. J Med Imaging Radiat Oncol. 2008;52:278–86.CrossRefPubMedGoogle Scholar
  60. 60.
    Jambusaria-Pahlajani A, Miller CJ, Quon H, et al. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg. 2009;35:574–85.CrossRefPubMedGoogle Scholar
  61. 61.
    Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer. 2007;109:1053–9.CrossRefPubMedGoogle Scholar
  62. 62.
    Mendenhall WM, Ferlito A, Takes RP, et al. Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol. 2012;48:918–22.CrossRefPubMedGoogle Scholar
  63. 63.
    Jambusaria-Pahlajani A, Hess SD, Katz KA, et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol. 2010;146:1225–31.CrossRefPubMedGoogle Scholar
  64. 64.
    Panizza B, Solares CA, Redmond M, et al. Surgical resection for clinical perineural invasion from cutaneous squamous cell carcinoma of the head and neck. Head Neck. 2012;34:1622–7.CrossRefPubMedGoogle Scholar
  65. 65.
    Hwang H, Perez D, Orloff L. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer. Laryngoscope. 2009;119:1958–65.CrossRefPubMedGoogle Scholar
  66. 66.
    Bron LP, Traynor SJ, McNeil EB, et al. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113:1070–5.CrossRefPubMedGoogle Scholar
  67. 67.
    Uren RF. Lymphatic drainage of skin. Ann Surg Oncol. 2004;11(3 Suppl):179S–85.CrossRefPubMedGoogle Scholar
  68. 68.
    Forest VI, Clark JJ, Veness MJ, et al. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer. 2010;116:1298–304.CrossRefPubMedGoogle Scholar
  69. 69.
    Kelder W, Ebrahimi A, Forest V, et al. Cutaneous head and neck squamous cell carcinoma with regional metastases: the prognostic importance of soft tissue metastases and extranodal spread. Ann Surg Oncol. 2012;19:274–9.PubMedCentralCrossRefPubMedGoogle Scholar
  70. 70.
    O’Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stages, extent of surgery and pathologic findings in metastatic cutaneous squamous cell carcinoma of the parotid gland. Head Neck. 2002;24:417–22.CrossRefPubMedGoogle Scholar
  71. 71.
    Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a mulitcenter study of treatment outcomes. Cancer. 2006;106:1078–83.CrossRefPubMedGoogle Scholar
  72. 72.
    American Joint Committee on Cancer. AJCC cancer staging handbook. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 301–14.CrossRefGoogle Scholar
  73. 73.
    Brunner M, Veness MJ, Ch’ng S, et al. Distant metastases from cutaneous squamous cell carcinoma—analysis of AJCC stage IV. Head Neck. 2013;35:72–5.CrossRefPubMedGoogle Scholar
  74. 74.
    O’Hara J, Ferlito A, Takes RP, et al. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland—a review of current recommendations. Head Neck. 2011;33:1789–95.CrossRefPubMedGoogle Scholar
  75. 75.
    Ambrosch P, Kron M, Pradier O, et al. Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2001;124:180–7.CrossRefPubMedGoogle Scholar
  76. 76.
    Chepeha DB, Hoff PT, Taylor RJ, et al. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112:434–8.CrossRefPubMedGoogle Scholar
  77. 77.
    Patel RS, Clark JR, Gao K, et al. Effectiveness of selective neck dissection in the treatment of the clinically positive neck. Head Neck. 2008;30:1231–6.CrossRefPubMedGoogle Scholar
  78. 78.
    Shepard PM, Olsen J, Harari PM, et al. Therapeutic selective neck dissection outcomes. Otolaryngol Head Neck Surg. 2010;142:741–6.CrossRefPubMedGoogle Scholar
  79. 79.
    Robbins KT, Ferlito A, Shah JP, et al. The evolving role of selective neck dissection for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013;270:1195–202.CrossRefPubMedGoogle Scholar
  80. 80.
    Wang JT, Palme CE, Wang AY, et al. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome. J Laryngol Otol. 2013;127 Suppl 1:S2–7.CrossRefPubMedGoogle Scholar
  81. 81.
    D’Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck. 2011;19:99–105.CrossRefGoogle Scholar
  82. 82.
    Iyer NG, Clark JR, Murali R, et al. Outcomes following parotidectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation. Head Neck. 2009;31:21–7.CrossRefPubMedGoogle Scholar
  83. 83.
    Cappiello J, Piazza C, Giudice M, et al. Shoulder disability after different selective neck dissections (levels II–IV versus levels II–V): a comparative study. Laryngoscope. 2005;115:259–63.CrossRefPubMedGoogle Scholar
  84. 84.
    Stuiver MM, van Wilgen CP, de Boer EM, et al. Impact of shoulder complaints after neck dissection on shoulder disability and quality of life. Otolaryngol Head Neck Surg. 2008;139:32–9.CrossRefPubMedGoogle Scholar
  85. 85.
    Veness MJ, Palme CE, Smith M, et al. Cutaneous head and neck squamous cell carcioma metastatic to cervical lymph nodes (non-parotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope. 2003;113:1827–33.CrossRefPubMedGoogle Scholar
  86. 86.
    Mendenhall WM, Amdur RJ, Hinerman RW, et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope. 2009;119:1994–9.CrossRefPubMedGoogle Scholar
  87. 87.
    Ebrahimi A, Clark J, Lorincz BB, et al. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient. Head Neck. 2012;34:365–70.CrossRefPubMedGoogle Scholar
  88. 88.
    Euvrard S, Morelon E, Rostaing L, TUMORAPA Study Group, et al. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329–39.CrossRefPubMedGoogle Scholar
  89. 89.
    Pramana A, Browne L, Graham PH. Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy. J Med Imaging Radiat Oncol. 2012;56:100–8.CrossRefPubMedGoogle Scholar

Copyright information

© Faruque Riffat, Carsten E. Palme, Michael Veness, Rehan Kazi, Raghav C. Dwivedi 2015

Authors and Affiliations

  • Carolyn Jameson
    • 1
  • Gary Morgan
    • 2
  • Carsten E. Palme
    • 3
  • Michael Veness
    • 4
    • 2
  1. 1.Head and Neck SurgeryRoyal Prince Alfred Hospital and Westmead HospitalSydneyAustralia
  2. 2.Head and Neck Surgery, Westmead HospitalUniversity of SydneySydneyAustralia
  3. 3.Otolaryngology Head and Neck SurgeryRoyal Prince Alfred Hospital and Westmead HospitalSydneyAustralia
  4. 4.Radiation Oncology, Westmead HospitalUniversity of SydneySydneyAustralia

Personalised recommendations